Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00427583
Status:
TERMINATED
Last Update Posted:
2012-08-07
First Post:
2007-01-25
Brief Title:
Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis